Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.4580 (-10.02%) ($0.4580 - $0.4580) on Thu. Apr. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.76% (three month average) | RSI | 47 | Latest Price | $0.4580(-10.02%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ANPC advances 3.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) TIP(50%) OIH(35%) GDX(34%) GDXJ(33%) MCHI(32%) | Factors Impacting ANPC price | ANPC will decline at least -5.38% in a week (0% probabilities). VIXM(-39%) ARKK(-17%) ARKG(-18%) UNG(-14%) XBI(-13%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.38% (StdDev 10.76%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $0.47(-2.55%) | 10 Day Moving Average | $0.46(-0.43%) | 20 Day Moving Average | $0.45(1.78%) | To recent high | -61% | To recent low | 16.9% | Market Cap | $4m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |